title: Topical tacrolimus 0.03% for the treatment of ocular psoriasis.
abstract: OBJECTIVE
  Cases are presented of 4 patients suffering from severe symptoms due to ocular psoriasis and who were treated with off-label 0.03% tacrolimus once a day.
  
  
  CONCLUSIONS
  All four patients had a mixed blepharitis and keratitis. Pseudopterygium and corneal opacities were present in three of them. All of them experienced an improvement of their itching and ocular surface. They all referred to a marked improvement of their quality of life in a follow-up period ranging from six months to two years. Therefore, topical tacrolimus could be considered an option in the treatment of ocular psoriasis.
authors.affiliation: Departamento de Oftalmología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España. Electronic address: pazrausin@telefonica.net.
authors.forename: P
authors.initials: P
authors.lastname: Rodríguez-Ausín
authors.affiliation: Departamento de Oftalmología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
authors.forename: D
authors.initials: D
authors.lastname: Antolín-Garcia
authors.affiliation: Departamento de Dermatología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
authors.forename: M
authors.initials: M
authors.lastname: Ruano Del Salado
authors.affiliation: Departamento de Oftalmología, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
authors.forename: C
authors.initials: C
authors.lastname: Hita-Antón
mesh_terms: D000287:Administration, Topical; D000368:Aged; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D016559:Tacrolimus / Q000008:administration & dosage*
chemical_list: D016559:Tacrolimus
keywords: Blefaritis; Blepharitis; Ocular psoriasis; Pseudopterygium; Psoriasis; Psoriasis ocular; Seudopterigión; Tacrolimus